Literature DB >> 15983678

Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes.

Mansour M Al-Nozha1, Abdel-Galil M Abdel-Gader, Mohammed R Arafah, Mohammed A Al-Maatouq, Maie S Al-Shahid, Saad S Al-Harthi, Nazeer B Khan, Moheeb A Abdullah.   

Abstract

OBJECTIVE: This study aims at characterizing the hemostatic changes, in a large cohort of Saudi Arab patients with acute coronary syndromes.
METHODS: We consecutively enrolled 389 patients (unstable angina [UA]: n=181; myocardial infarction [MI]: n=208) in this study at King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia in the period from April 2000 to November 2001. We collected blood samples before coronary angiography. Controls (n=101) were healthy males and females. All hemostatic assays were undertaken using enzyme linked immunosorbent assay based techniques and commercial kits.
RESULTS: The mean plasma levels of both bound and free tissue factor pathway inhibitors (TFPI) were significantly higher and to comparable levels, in patients with MI and UA, than in healthy control levels. Markers of thrombin generation: the mean levels of prothrombin fraction 1+2, thrombin antithrombin complexes, and D-Dimer were very significantly elevated in the 2 patients groups than in controls. Proteins C and antithrombin III showed statistically significant reduction especially in patients with MI. Plasminogen activator inhibitor levels were significantly elevated in the 2 patient groups, but were higher in MI patients. The mean levels of fibrinogen and D-Dimer as well thrombin antithrombin complex were higher and the levels of free tissue factor pathway inhibitor were lower in patients with 3-vessel coronary artery disease than those with single and double vessel disease.
CONCLUSION: The results of this study confirm the existence, and to a similar extent, of a hypercoagulable state in Saudi patients with MI than UA and in those with 3-vessel coronary artery disease than those with one or 2-vessel disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983678

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

Review 1.  Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.

Authors:  Mark Y Chan; Jeffrey I Weitz; Yahye Merhi; Robert A Harrington; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2009-10       Impact factor: 2.300

2.  Circulating thrombotic and haemostatic components in patients with coronary artery disease.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S S Payannavar; A P Walvalkar; R A Mokal; S M Mithbawkar; K V Kudalkar; A Abraham; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.